Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00456924 | Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914 | PHASE2 | COMPLETED | 48 | — | — | Jan 1, 2004 | Dec 1, 2004 | Jun 17, 2010 | 4 | Belgium, France |
| Name | Type | Description |
|---|---|---|
| VA2914 | DRUG | - |
Inclusion Criteria: * women in good general health with regular, ovulatory menstrual cycles * age 18-35 * not pregnant * not sexually active or reliably use barrier methods of contraception * normal liver and renal functions and normal laboratory exams Exclusion Criteria: * pregnant or breastfeed...